Medline Industries
Medline Industries, Inc., a leading global manufacturer and distributor of healthcare supplies, is headquartered in the United States. Founded in 1910, the company has established a strong presence in North America and beyond, serving hospitals, nursing homes, and other healthcare facilities. Medline is renowned for its extensive range of products, including surgical instruments, medical apparel, and infection prevention solutions, all designed to enhance patient care and operational efficiency. With a commitment to innovation, Medline has achieved significant milestones, such as expanding its product lines and investing in advanced manufacturing technologies. The company holds a prominent market position, recognised for its quality and reliability, making it a trusted partner in the healthcare industry. Medline's dedication to customer service and tailored solutions further distinguishes it in a competitive landscape.
DitchCarbon Score
How does Medline Industries's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medline Industries's score of 41 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medline Industries's reported carbon emissions
In 2023, Medline Industries reported total carbon emissions of approximately 4,842,500 kg CO2e, with emissions distributed across various scopes: 1,330 kg CO2e (Scope 1), 11,310 kg CO2e (Scope 2), and a significant 4,716,100 kg CO2e (Scope 3). This data reflects a notable decrease from 2022, when total emissions were about 792,770 kg CO2e, indicating a shift in their operational impact. Medline Industries has set ambitious climate commitments, aiming for a 30% reduction in Scope 1 and Scope 2 emissions from a 2023 baseline by 2030. Additionally, they are committed to achieving Net Zero emissions by 2050, with projections indicating a reduction of total Scope 1 and Scope 2 emissions to 63 tCO2e by 2030, representing a 42% absolute reduction. For Scope 3 emissions, they project a decrease to 513 tCO2e by 2030, which is a 25% reduction based on the five sub-categories required by the NHS in 2023. These commitments are part of Medline's broader strategy to enhance sustainability and reduce their carbon footprint, aligning with industry standards and climate action goals. The emissions data and reduction targets are sourced from Medline Industries, Inc., reflecting their corporate responsibility initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 45,201,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 81,309,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | 90,611,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medline Industries is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
